Andrew R. Kompa

3.5k total citations
89 papers, 2.8k citations indexed

About

Andrew R. Kompa is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Andrew R. Kompa has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 26 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in Andrew R. Kompa's work include Cardiac Fibrosis and Remodeling (16 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (14 papers) and Heart Failure Treatment and Management (14 papers). Andrew R. Kompa is often cited by papers focused on Cardiac Fibrosis and Remodeling (16 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (14 papers) and Heart Failure Treatment and Management (14 papers). Andrew R. Kompa collaborates with scholars based in Australia, United States and Canada. Andrew R. Kompa's co-authors include Henry Krum, Bing H. Wang, Darren J. Kelly, Suree Lekawanvijit, Roger J. Summers, Anastasia Adrahtas, Thomas G. von Lueder, Dan Atar, Fiona See and Silviu Itescu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Andrew R. Kompa

87 papers receiving 2.8k citations

Peers

Andrew R. Kompa

CCM

SURGE

NEPHR

EDM

Syamal K. Bhattacharya United States

Jorge E. Toblli Argentina

Koichiro Homma Japan

Ming‐Shien Wen Taiwan

Ivonne Hernandez Schulman United States

Pingjin Gao China

Bei Sun China

Koichi Sugamura Japan

Junxi Lu China

Masaaki Miyata Japan

Syamal K. Bhattacharya United States

Andrew R. Kompa

1.1k ×0.8

CCM

959 ×1.2

475 ×0.8

SURGE

206 ×0.4

NEPHR

666 ×2.1

EDM

Citations per year, relative to Andrew R. Kompa Andrew R. Kompa (= 1×) peers Syamal K. Bhattacharya

Countries citing papers authored by Andrew R. Kompa

Since Specialization

Citations

This map shows the geographic impact of Andrew R. Kompa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Kompa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Kompa more than expected).

Fields of papers citing papers by Andrew R. Kompa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew R. Kompa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Kompa. The network helps show where Andrew R. Kompa may publish in the future.

Co-authorship network of co-authors of Andrew R. Kompa

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew R. Kompa. A scholar is included among the top collaborators of Andrew R. Kompa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew R. Kompa. Andrew R. Kompa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Savira, Feby, Ruth Magaye, Bernard L. Flynn, et al.. (2021). Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. Toxicology Letters. 350. 133–142. 9 indexed citations

Kompa, Andrew R., David W. Greening, Anne M. Kong, et al.. (2020). Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction. Cardiovascular Research. 117(3). 918–929. 54 indexed citations

Zhang, Yuan, Amanda J. Edgley, Alison J. Cox, et al.. (2012). FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy. European Journal of Heart Failure. 14(5). 549–562. 41 indexed citations

See, Fiona, Masataka Watanabe, Andrew R. Kompa, et al.. (2012). Early and Delayed Tranilast Treatment Reduces Pathological Fibrosis Following Myocardial Infarction. Heart Lung and Circulation. 22(2). 122–132. 28 indexed citations

Liu, Shan, Andrew R. Kompa, Darren J. Kelly, Henry Krum, & Bing H. Wang. (2011). Abstract 11507: Subtotal Nephrectomy Accelerates Pathological Cardiac Remodelling Post Myocardial Infarction: Recapitulating the Phenotype of Cardiorenal Syndrome?. Circulation. 124. 1 indexed citations

Lekawanvijit, Suree, et al.. (2011). Abstract 11416: Reduction of Renal Fibrosis as Well as Cardiac Pro-fibrotic and Pro-Inflammatory mRNA Expression by an Oral Charcoal Adsorbent, AST-120, in Post-MI Rats. Circulation. 1 indexed citations

Wang, Bing H., et al.. (2011). Abstract 12344: Apoptosis Signal-Regulating Kinase 1 Inhibition Attenuates Cardiac Myocyte Hypertrophy and Fibroblast Collagen Synthesis Stimulated by Angiotensin II- and TGFβ: Therapeutic Potential of ASK1 Inhibitors in Myocardial Remodelling. Circulation. 124. 2 indexed citations

Lekawanvijit, Suree, et al.. (2010). Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?. European Heart Journal. 31(14). 1771–1779. 255 indexed citations

Kompa, Andrew R., Bing H. Wang, Arintaya Phrommintikul, et al.. (2010). Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy. Peptides. 31(8). 1523–1530. 17 indexed citations

10.

Rana, Indrajeetsinh, Martin J. Stebbing, Andrew R. Kompa, et al.. (2010). Microglia activation in the hypothalamic PVN following myocardial infarction. Brain Research. 1326. 96–104. 78 indexed citations

11.

Phrommintikul, Arintaya, Lavinia Tran, Andrew R. Kompa, et al.. (2008). Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 294(4). H1804–H1814. 98 indexed citations

12.

Morritt, Andrew N., Susan Bortolotto, Rodney J. Dilley, et al.. (2007). Cardiac Tissue Engineering in an In Vivo Vascularized Chamber. Circulation. 115(3). 353–360. 157 indexed citations

13.

Martín, J., Kim A. Connelly, Andrew R. Kompa, et al.. (2006). Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction: benefit of statin therapy. European Heart Journal. 27. 522–523. 1 indexed citations

14.

Zomer, Ella, Andrew R. Kompa, Paul A. Komesaroff, & Henry Krum. (2006). Urotensin II is a vasoconstrictor in diabetic patients without heart failure or essential hypertension. European Heart Journal. 27. 532–532. 1 indexed citations

15.

Kompa, Andrew R., et al.. (2005). Effect of rho-kinase inhibition on collagen production in isolated cardiac fibroblasts. European Heart Journal. 26. 66–66. 1 indexed citations

16.

See, Fiona, Walter G. Thomas, Kerrie J. Way, et al.. (2004). p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. Journal of the American College of Cardiology. 44(8). 1679–1689. 149 indexed citations

17.

Krum, Henry, Andrew R. Kompa, Ross D. Hannan, & Walter G. Thomas. (2003). Emerging Role of the Urotensin II System in Cardiovascular Disease. 3(3). 153–158. 2 indexed citations

18.

Kompa, Andrew R. & Roger J. Summers. (2000). Lidocaine and surgical modification reduces mortality in a rat model of cardiac failure induced by coronary artery ligation. Journal of Pharmacological and Toxicological Methods. 43(3). 199–203. 20 indexed citations

19.

Kompa, Andrew R., Peter Molenaar, & Roger J. Summers. (1995). ?-Adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting ?2-adrenoceptor agonist formoterol. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(6). 576–88. 4 indexed citations

20.

Russell, Fraser D., Andrew R. Kompa, Peter Molenaar, & Roger J. Summers. (1994). Regulation of ß-adrenoceptors in the guinea-pig sinoatrial node. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(5). 463–472. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact